Pei Wenwen, Xu Liling, Zhong Hua, Wang Ziye, Yao Ranran, Zhang Lei, Yang Jing, Li Jingyang, Feng Yuan, Lin Qi, Li Dongsheng, Zhou Xinyao, Pei Dongxue, Guo Yanqiu, Ma Li, Luo Yaping, Zuo Shufei, Wang Lin, Yan Rui, Su Yin
Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China.
Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
Clin Rheumatol. 2025 Mar;44(3):969-978. doi: 10.1007/s10067-024-07262-2. Epub 2025 Jan 24.
This study aimed to analyze and compare the proportion of patients with different types of inflammatory arthritis and investigate the clinical characteristics, including symptoms and signs, medication choices, and disease activity, in the daily clinical practice of China.
Patients with inflammatory arthritis were recruited from 16 Grade-A tertiary hospitals between August 2021 and April 2022. The medical profiles, encompassing sociodemographic characteristics, clinical and laboratory date, were collected.
This study included 2,693 patients with arthritis, with rheumatoid arthritis (RA) accounting for the highest proportion (50.50%). Significant differences were observed in terms of age, gender, body mass index (BMI), disease duration, smoking and family history among patients with different types of inflammatory arthritis. Physical activity and cold exposure were identified as the main predisposing factors for RA, psoriatic arthritis (PsA), osteoarthritis (OA), and ankylosing spondylitis (AS), while alcohol consumption was the most common inducing factor for gout. Hypertension and hyperlipidemia were the primary concomitant diseases in RA, OA, and AS, whereas hyperuricemia and hypertension were mainly associated with gout, psoriasis and diabetes were the most common comorbidities in PsA. Peripheral joints were predominantly affected in PsA, RA, OA, and gout, while axial joints were mainly affected in AS. Methotrexate and leflunomide were the main therapeutic drugs for RA, while biologics were commonly prescribed for PsA and AS. OA and gout patients mainly utilized nonsteroidal anti-inflammatory drugs (NSAIDs).
Patients with different types of inflammatory arthritis exhibited varying predisposing factors, joint inflammation, concomitant diseases, and medication choices, highlighting the importance of individualized approaches in the clinic. Key Points • 2,693 patients classified and diagnosed with inflammatory arthritis were recruited in this study from 16 Grade-A tertiary hospitals in China between August 2021 and April 2022. • This study analyzed and compared the proportion of patients with different types of arthritis in routine clinical practice in China. • Joint inflammation, comorbidities, and medication choices were assessed among patients with the most common types of arthritis in this study. • This study also provided some epidemiologically relevant information about inflammatory arthritis patients in China.
本研究旨在分析和比较不同类型炎症性关节炎患者的比例,并调查在中国日常临床实践中这些患者的临床特征,包括症状和体征、药物选择及疾病活动情况。
2021年8月至2022年4月期间,从16家三级甲等医院招募炎症性关节炎患者。收集患者的医疗资料,包括社会人口统计学特征、临床和实验室数据。
本研究纳入了2693例关节炎患者,其中类风湿关节炎(RA)占比最高(50.50%)。不同类型炎症性关节炎患者在年龄、性别、体重指数(BMI)、病程、吸烟及家族史方面存在显著差异。身体活动和寒冷暴露被确定为RA、银屑病关节炎(PsA)、骨关节炎(OA)和强直性脊柱炎(AS)的主要诱发因素,而饮酒是痛风最常见的诱发因素。高血压和高脂血症是RA、OA和AS的主要合并症,而高尿酸血症和高血压主要与痛风相关,银屑病和糖尿病是PsA最常见的合并症。PsA、RA、OA和痛风主要累及外周关节,而AS主要累及中轴关节。甲氨蝶呤和来氟米特是RA的主要治疗药物,而生物制剂常用于PsA和AS的治疗。OA和痛风患者主要使用非甾体抗炎药(NSAIDs)。
不同类型炎症性关节炎患者表现出不同的诱发因素、关节炎症、合并症及药物选择,凸显了临床上个体化治疗方法的重要性。要点 • 本研究于2021年8月至2022年4月期间,从中国16家三级甲等医院招募了2693例经分类诊断的炎症性关节炎患者。 • 本研究分析并比较了中国常规临床实践中不同类型关节炎患者的比例。 • 本研究评估了最常见类型关节炎患者的关节炎症、合并症及药物选择。 • 本研究还提供了一些与中国炎症性关节炎患者相关的流行病学信息。